AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 162 min read$TER

MATZ MARILYN sold $508K of TER

MATZ MARILYN sold 1,200 shares of TERADYNE, INC (TER) at $423.03 ($0.51M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MATZ MARILYN
Published Jun 16, 2026, 10:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

A director’s open-market sale under a pre-arranged 10b5-1 plan is typically treated as non-informational; the main trading relevance is sentiment/positioning rather than fundamentals.

02

Market read

Traders may note the insider sale for sentiment, but there is no new guidance, deal, or operational catalyst in the text.

03

What to watch

The article provides only one director sale size and does not indicate whether other insiders are buying/selling around the same window.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-16; transaction dated 2026-06-15

Background

The article is a SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne director Marilyn Matz sold 1,200 shares at $423.03 via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be short-lived.

Evidence & confidence

The filing is an insider sale (not a buy), explicitly under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

Sector

No sector read-across; this is company-specific insider transaction disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may still fade rallies if other selling emerges.

Key entities

  • issuer
    TERADYNE, INC

    US-listed company whose director insider sale is disclosed on Form 4.

  • insider
    MATZ MARILYN

    Director who sold 1,200 shares of TER under a pre-arranged 10b5-1 plan.

Read at source← All news

Related articles

AUG 4
$TERMed

5 Revealing Analyst Questions From Teradyne’s Q2 Earnings Call

Teradyne reported Q2 revenue of $1.33B vs $1.22B expected and adjusted EPS of $2.47 vs $2.05, citing AI-driven demand across semiconductor test, product test, and robotics. CEO Gregory Smith said over 60% of revenue is AI-related. Q3 guidance calls for $1.25B revenue and $2.00 adjusted EPS at midpoint. Analysts asked about test equipment share, wafer-to-data-center strategy, memory drivers, and CPU vs GPU testing.

financialcontent.com6 min
AUG 2
$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne (NASDAQ: TER) shares rose about 3.3% midday after Q2 results and guidance beat expectations. The company reported non-GAAP EPS of $2.47 on revenue of $1.33B, topping analyst forecasts by $0.42 and about $110M, respectively. Q3 guidance calls for revenue $1.2B to $1.3B and adjusted EPS $1.85 to $2.15, both above estimates, though gains eased amid broader macro concerns.

aol.com2 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$TERMed

Why Teradyne (TER) Stock Is Trading Up Today

Teradyne (NASDAQ: TER) shares rose about 12.5% after the company reported strong Q2 results. Revenue was about $1.3 billion, more than double year over year, driven by demand for AI test equipment. Management said AI-related orders now exceed 60% of the business. The move followed broader semiconductor weakness tied to China and AI demand concerns.

financialcontent.com4 min
JUL 29
$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne shares rose 3.3% around 1 p.m. ET despite declines in the S&P 500 and Nasdaq. After reporting Q2 results, the company posted non-GAAP EPS of $2.47 on revenue of $1.33B, beating analyst expectations, and provided Q3 guidance of $1.2B to $1.3B revenue and $1.85 to $2.15 adjusted EPS.

fool.com4 min